Customer Notification: Change in Screening assay for Mumps IgM and Measles IgM antibodies

Printer-friendly versionPrinter-friendly version

The NVRL is pleased to notify users that following a successful verification Liaison™ Measles IgM and Liaison™ Mumps IgM assays are to be introduced as screening assays for blood samples from Monday 4th September 2023.

The current Microimmune™ assays for these infection markers will no longer be in use.


The wording on NVRL reports after this date will reflect this change.


Any queries in relation to this notification should be addressed to the Clinical Team on 01-7164401.